Researchers at Tohoku University have discovered that an oral drug called MA-5 can improve both heart and muscle problems in ...

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...

Barth Syndrome: A rare X‐linked genetic disorder characterised by cardiomyopathy, skeletal myopathy, growth delay and metabolic abnormalities due to mutations in the TAZ gene.

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...

Barth syndrome is a rare genetic disorder with no known cure. Researchers at Tohoku University examined a new oral drug called MA-5 that could provide life-changing relief to these young patients.

Approximately 150 people live with Barth Syndrome nationwide, an ultra-rare genetic disorder that affects only males and impacts muscle and heart muscle health.

By Sooji Nam. Click here for updates on this story. SAN FRANCISCO — With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...